Volume 21 No 1 (2023)
Download PDF
Clinical trial to assess the effect of homoeopathic nanomedicine in patients with chronic insomnia in the age group of 35- 65 years
Dr. Ketaki Bhat, Dr. Arun Jadhav
Abstract
The corpus of research indicates that homoeopathic formulas create incredibly small particles,
which are called as nanoparticles. These nanoparticles have electromagnetic or quantum
properties when likened to their mass or the first structures. Hence, can be used as
Homoeopathic personalised nanomedicines. As per few overviews, about 25-30% of the
population suffers with insomnia in some form or another. Insomnia is a problem that can
induce daytime weariness, poor focus, and irritation, according to prior study. It reduces the
quality of life and increases the risk of several diseases. It influences a person's social,
occupational, and general functioning. Insomnia, despite this, goes ignored and mistreated.
Researchers suggest that Homoeopathy can be used to treat chronic insomnia without
causing drug dependence or side effects. This study was aimed to investigate whether
homoeopathic nanomedicines have effect in the treatment of patients with chronic insomnia.
This study is a single-blind, non-randomized clinical trial. The improvement in sleep pattern
was noted using sleep diary maintained by the patients and Insomnia Severity Index Score
which was calculated before and after the study. The outcome of this study was significant
improvement in chronic insomnia using homoeopathic medicines. Paired ‘t’ test was used to
analyse the result. The before treatment ISI value was 18.33 ± 2.16, after treatment ISI value
reduced to 7.80 ± 3.66. This suggests that Homoeopathic nanomedicines prescribed based on
totality shows significant improvement in chronic insomnia. 90% of the patients showed
significant improvement in associated symptoms.
Keywords
Chronic, Homoeopathy, individualisation, Insomnia, nanomedicine.
Copyright
Copyright © Neuroquantology
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the Neuroquantology are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJECSE right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.